AstraZeneca PLC Board Committee Changes (6059X)
27 April 2023 - 4:05PM
UK Regulatory
TIDMAZN
RNS Number : 6059X
AstraZeneca PLC
27 April 2023
27 April 2023 07:05 BST
AstraZeneca Board Committee Changes
AstraZeneca PLC (the Company) announced today a number of Board
Committee changes:
> Michel Demaré will succeed Leif Johansson as Chair of the
Nomination and Governance Committee, with effect from the
conclusion of the Company's Annual General Meeting today, 27 April
2023.
> Nazneen Rahman will become a member of the Remuneration Committee, effective 1 May 2023.
> Euan Ashley will succeed Nazneen Rahman as Chair of the
Science Committee, effective 1 June 2023. Dr Rahman will remain as
a member of the Science Committee.
> Euan Ashley will become a member of the Nomination and
Governance Committee, effective 1 June 2023.
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led
biopharmaceutical company that focuses on the discovery,
development, and commercialisation of prescription medicines in
Oncology, Rare Diseases, and BioPharmaceuticals, including
Cardiovascular, Renal & Metabolism, and Respiratory &
Immunology. Based in Cambridge, UK, AstraZeneca operates in over
100 countries and its innovative medicines are used by millions of
patients worldwide. Please visit astrazeneca.com and follow the
Company on Twitter @AstraZeneca .
Contacts
For details on how to contact the Investor Relations Team,
please click here . For Media contacts, click here .
Adrian Kemp
Company Secretary
AstraZeneca PLC
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCPPUAGCUPWGMQ
(END) Dow Jones Newswires
April 27, 2023 02:05 ET (06:05 GMT)
Astrazeneca (LSE:0A4J)
Historical Stock Chart
From Apr 2024 to May 2024
Astrazeneca (LSE:0A4J)
Historical Stock Chart
From May 2023 to May 2024